EndoMAXX Endoluminal Valve Technology (EVT) Compared to EndoMAXX
Prospective, Multicenter, Single Blind, Randomized Study Comparing the EndoMAXX Endoluminal Valve Technology (EVT) Fully Covered Esophageal Stent With Valve to the EndoMAXX Fully Covered Esophageal Stent for Malignant Strictures Requiring Stent Placement Across the Gastroesophageal Junction
Sponsor: Geisinger Clinic
This NA trial investigates Malignant Esophageal Strictures and is currently completed. Geisinger Clinic leads this study, which shows 11 recorded versions since 2015 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
11 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2023 — Jul 2024 [monthly]
Completed NA
-
Dec 2022 — Jan 2023 [monthly]
Completed NA
-
Jan 2021 — Dec 2022 [monthly]
Completed NA
▶ Show 6 earlier versions
-
Feb 2020 — Jan 2021 [monthly]
Completed NA
-
Jul 2018 — Feb 2020 [monthly]
Completed NA
Phase: PHASE3 → NA
-
Jun 2018 — Jul 2018 [monthly]
Completed PHASE3
-
May 2017 — Jun 2018 [monthly]
Completed PHASE3
Status: Active Not Recruiting → Completed
-
Feb 2017 — May 2017 [monthly]
Active Not Recruiting PHASE3
-
Jan 2017 — Feb 2017 [monthly]
Active Not Recruiting PHASE3
First recorded
Jan 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Geisinger Clinic
- Indiana University
- Mayo Clinic
- Medical College of Wisconsin
- Merit Medical Systems, Inc.
- University of Colorado, Denver
- University of Florida
- Weill Medical College of Cornell University
For direct contact, visit the study record on ClinicalTrials.gov .